Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma:: a phase I/II study

被引:51
作者
Löhr, M
Bago, ZT
Bergmeister, H
Ceijna, M
Freund, R
Gelbmann, W
Günzburg, WH
Jesnowski, R
Hain, J
Hauenstein, K
Henninger, W
Hoffmeyer, A
Karle, P
Kröger, JC
Kundt, G
Liebe, S
Losert, U
Müller, P
Probst, A
Püschel, K
Renner, M
Renz, R
Saller, R
Salmons, B
Schuh, M
Schwendenwein, I
von Rombs, K
Wagner, T
Walter, I
机构
[1] Univ Rostock, Dept Med, D-18057 Rostock, Germany
[2] Univ Rostock, Dept Biometry, D-18057 Rostock, Germany
[3] Univ Vet Sci, Dept Med 2, A-1210 Vienna, Austria
[4] Inst Histol & Embryol, A-1210 Vienna, Austria
[5] Univ Vet Sci, Inst Anat, A-1210 Vienna, Austria
[6] Univ Vet Sci, Inst Virol, A-1210 Vienna, Austria
[7] Univ Vet Sci, Inst Radiol, A-1210 Vienna, Austria
[8] Univ Vet Sci, Inst Pathol, A-1210 Vienna, Austria
[9] Univ Vet Sci, Gen Hosp, Biomed Res Ctr, A-1210 Vienna, Austria
[10] Univ Lubeck, Dept Med, D-23538 Lubeck, Germany
[11] Bavarian Nord Res Inst GmbH, D-82152 Martinsried, Germany
[12] Univ Rostock, Dept Diagnost Radiol, D-18057 Rostock, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1999年 / 77卷 / 04期
关键词
D O I
10.1007/s001090050366
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:393 / 398
页数:6
相关论文
共 27 条
[1]   ADJUVANT THERAPY WITH CHEMOTHERAPY AND RADIATION-THERAPY IN THE MANAGEMENT OF CARCINOMA OF THE PANCREATIC HEAD [J].
ADAMS, RA ;
GROCHOW, LB .
SURGICAL CLINICS OF NORTH AMERICA, 1995, 75 (05) :925-+
[2]  
Ahlgren JD, 1996, CANCER-AM CANCER SOC, V78, P654
[3]  
BENARD J, 1990, ANTICANCER RES, V10, P1297
[4]   Phase II study of gemcitabine in patients with advanced pancreatic cancer [J].
Carmichael, J ;
Fink, U ;
Russell, RCG ;
Spittle, MF ;
Harris, AL ;
Spiessi, G ;
Blatter, J .
BRITISH JOURNAL OF CANCER, 1996, 73 (01) :101-105
[5]   CONTINUOUS 5-DAY INFUSION OF IFOSFAMIDE WITH MESNA IN INOPERABLE PANCREATIC-CANCER PATIENTS - A PHASE-II STUDY [J].
CERNY, T ;
MARTINELLI, G ;
GOLDHIRSCH, A ;
TERRIER, F ;
JOSS, R ;
FEY, MF ;
BRUNNER, KW ;
KUPFER, A .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1991, 117 :S135-S138
[6]  
CHABOT GG, 1994, ANTICANCER RES, V14, P2269
[7]  
Chen L, 1996, CANCER RES, V56, P1331
[8]  
CRANDELL RA, 1973, IN VITRO CELL DEV B, V9, P176, DOI 10.1007/BF02618435
[9]   Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases [J].
Dirven, HAAM ;
vanOmmen, B ;
vanBladeren, PJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (02) :351-360
[10]   A MICROASSAY FOR MEASURING CYTOCHROME-P450IA1 AND CYTOCHROME-P450IIB1 ACTIVITIES IN INTACT HUMAN AND RAT HEPATOCYTES CULTURED ON 96-WELL PLATES [J].
DONATO, MT ;
GOMEZLECHON, MJ ;
CASTELL, JV .
ANALYTICAL BIOCHEMISTRY, 1993, 213 (01) :29-33